The clinical and genetic heterogeneity of Triple Negative Breast Cancer (TNBC) and the lack of unambiguous molecular targets contribute to the inadequacy of current therapeutic options for these variants. MicroRNAs (miRNA) are a class of small highly conserved regulatory endogenous non-coding RNA, which can alter the expression of genes encoding proteins and may play a role in the dysregulation of cellular pathways. | MiRNA-135b contributes to Triple Negative Breast Cancer molecular heterogeneity: Different expression profile in Basal-like versus non-Basal-like phenotypes
